FDA revokes approval of Avastin for breast cancer

[News]

The commissioner of the Food and Drug Administration on Friday revoked the approval of the drug Avastin as a treatment for breast cancer, ruling in an emotional issue that pitted the hopes of some desperate patients against the statistics of clinical trials.

More... (http://www.news-medical.net/news/20111119/FDA-revokes-approval-of-Avastin-for-breast-cancer.aspx)